《瑞银窝轮》资金转吼二线新经济股 留意好医生、小米、美团CALL
受地缘政治局势升温所拖累，恒指本周中段曾失守28000点心理关口，但即市已收复失地，在港股下跌期间，尤其星期三急跌时，一众新经济股仍然有较强的表现仍不俗，以周三(8日)为例，当日市值大的新经济股阿里巴巴(9988)、腾讯(0700)及美团(3690)虽然都有回落，但整体走势仍处近期高位；相对二线的平安好医生(1833)、小米(1810)都逆市造好，反映资金在调整市况中，并未离开股市，而转投较少受指数影响的二线股份。
新年伊始，市场都在寻找今年的潜质股，上述3只被憧憬为有机会覆制去年的美团例子。投资者如看好医生有机会破60港元、小米有机会受惠5G换机潮的话，可考虑以下CALL轮部署：
平医认购14368，行使价62.85港元，20年5月到期，有效杠杆约3.5倍。
小米认购17041，行使价11.02港元，20年3月到期，有效杠杆约8.4倍。
其它新经济股CALL轮精选：
阿里认购17813，行使价246港元，20年6月到期，有效杠杆约8.4倍。
腾讯认购18857，行使价420.08港元，20年6月到期，有效杠杆约8.2倍。
众安(6060)认购13249，行使价30.88港元，20年5月到期，有效杠杆约5.3倍。
美团认购17054，行使价125.35港元，20年7月到期，有效杠杆约5.6倍。
更多窝轮牛熊资讯：瑞银证网站: www.ubs.com/hkwarrant
窝证教学及市况焦点短片:
https://www.youtube.com/channel/UCKw86qy4eBAInmd52MND45Q?view_as=subscriber周国威董事
瑞银亚洲股票衍生产品销售部
本产品并无抵押品。 如发行人无力偿债或违约,投资者可能无法收回部份或全部应收款项。笔者为UBS AG的代表(作为证监会持牌人)，并未持有相关上市公司的任何财务权益。本资料由瑞银刊发，其并不构成买卖建议、邀请、要约或游说。结构性产品价格可急升或急跌，投资者可能会蒙受全盘损失。过往表现并不反映将来表现。牛熊证备强制赎回机制而可能被提早终止，届时 (i) N类牛熊证投资者将不获发任何金额;而(ii) R类牛熊证之剩余价值可能为零。投资前应了解有关风险，并谘询专业顾问及查阅有关上市文件。UBS Securities Hong Kong Limited为结构性产品之流通量提供者，亦可能是唯一报价者或市场参与者。(C) UBS 2020。版权所有。~重要声明:
以上资讯由第三方提供，AASTOCKS.com Limited对於任何包含於、经由、连结、下载或从任何与本网站有关服务所获得之资讯、内容或广告，不声明或保证其内容之正确性或可靠性。对於您透过本网站上之广告、资讯或要约而展示、购买或取得之任何产品、资讯资料，本公司亦不负品质保证之责任。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
